Cost-Effectiveness and Cost-Utility of the Adherence Improving self-Management Strategy (AIMS) in HIV-Care : A Trial-Based Economic Evaluation
Citation
Wijnen , B F M , Oberjé , E J M , Evers , S M A A , Prins , J M , Nobel , H-E , van Nieuwkoop , C , Veenstra , J , Pijnappel , F J , Kroon , F P , van Zonneveld , L , Van Hulzen , A G W , van Broekhuizen , M & de Bruin , M 2019 , ' Cost-Effectiveness and Cost-Utility of the Adherence Improving self-Management Strategy (AIMS) in HIV-Care : A Trial-Based Economic Evaluation ' , Clinical Infectious Diseases , vol. 68 , no. 4 , pp. 658-667 . https://doi.org/10.1093/cid/ciy553
URI
http://hdl.handle.net/2164/12936http://www.scopus.com/inward/record.url?scp=85060990822&partnerID=8YFLogxK
http://www.mendeley.com/research/costeffectiveness-costutility-adherence-improving-selfmanagement-strategy-human-immunodeficiency-vir-1
Rights
This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical Infectious Diseases following peer review. The version of record Ben F M Wijnen, Edwin J M Oberjé, Silvia M A A Evers, Jan M Prins, Hans-Erik Nobel, Cees van Nieuwkoop, Jan Veenstra, Frank J Pijnappel, Frank P Kroon, Laura van Zonneveld, Astrid G W van Hulzen, Marjolein van Broekhuizen, Marijn de Bruin; Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation, Clinical Infectious Diseases, Volume 68, Issue 4, 1 February 2019, Pages 658–667., is available online at: https://doi.org/10.1093/cid/ciy553